Drugs for Non-small Cell Lung Cancer Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

1 Industrial Chain Overview

1.1 Drugs for Non-small Cell Lung Cancer Industry

1.1.1 Overview

Figure Drugs for Non-small Cell Lung Cancer Picture List

1.1.2 Characteristics of Drugs for Non-small Cell Lung Cancer

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Radiofrequency Ablation (RFA) 

1.3.2 Radiation Therapy 

1.3.3 Chemotherapy 

1.3.4 Targeted Therapies 

1.3.5 Immunotherapy

1.4 End-Use List

1.4.1 Demand in Hospital 

1.4.2 Demand in Clinic 

1.4.3 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2016-2026

Figure Global Market Size and Forecast with Growth Rate, 2016-2026

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026

Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026

Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026

Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume

Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD

2.1.2 Global Consumption

Figure Global Market Volume and Growth Rate, 2016-2020, in Volume

Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume

Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.2 North America

Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume

Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.3 South America

Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume

Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.4 Europe

Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.5 Middle East & Africa

Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.2 Consumption

2.2.2.1 Asia-Pacific

Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume

Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.2 North America

Figure North America Market Volume and Growth Rate, 2016-2020, in Volume

Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD

Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.3 South America

Figure South America Market Volume and Growth Rate, 2016-2020, in Volume

Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD

Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.4 Europe

Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume

Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.5 Middle East & Africa

Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume

Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

3.2 Manufacturers List

3.2.1 Bristol-Myers Squibb  Overview

Table Bristol-Myers Squibb  Overview List

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Bristol-Myers Squibb  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 GlaxoSmithKline  Overview

Table GlaxoSmithKline  Overview List

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of GlaxoSmithKline  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Menarini  Overview

Table Menarini  Overview List

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Menarini  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Sanofi  Overview

Table Sanofi  Overview List

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Sanofi  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Ziopharm Oncology  Overview

Table Ziopharm Oncology  Overview List

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Ziopharm Oncology  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Alchemia  Overview

Table Alchemia  Overview List

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Alchemia  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Amgen  Overview

Table Amgen  Overview List

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Amgen  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Apotex  Overview

Table Apotex  Overview List

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Apotex  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 BioMarin Pharmaceutical  Overview

Table BioMarin Pharmaceutical  Overview List

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of BioMarin Pharmaceutical  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 CellAct Pharma  Overview

Table CellAct Pharma  Overview List

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of CellAct Pharma  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 Cerulean Pharma  Overview

Table Cerulean Pharma  Overview List

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cerulean Pharma  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Cipla  Overview

Table Cipla  Overview List

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cipla  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Cornerstone Pharmaceuticals  Overview

Table Cornerstone Pharmaceuticals  Overview List

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cornerstone Pharmaceuticals  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Curis  Overview

Table Curis  Overview List

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Curis  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 CytRx  Overview

Table CytRx  Overview List

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of CytRx  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Eli Lilly  Overview

Table Eli Lilly  Overview List

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Eli Lilly  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Exelixis  Overview

Table Exelixis  Overview List

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Exelixis  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 Fresenius Kabi  Overview

Table Fresenius Kabi  Overview List

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Fresenius Kabi  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

3.2.19 Genentech  Overview

Table Genentech  Overview List

3.2.19.1 Product Specifications

3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Genentech  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.19.3 Recent Developments

3.2.19.4 Future Strategic Planning

3.2.20 Hikma Pharmaceuticals  Overview

Table Hikma Pharmaceuticals  Overview List

3.2.20.1 Product Specifications

3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Hikma Pharmaceuticals  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.20.3 Recent Developments

3.2.20.4 Future Strategic Planning

3.2.21 Hospira  Overview

Table Hospira  Overview List

3.2.21.1 Product Specifications

3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Hospira  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.21.3 Recent Developments

3.2.21.4 Future Strategic Planning

3.2.22 Intas Pharmaceuticals  Overview

Table Intas Pharmaceuticals  Overview List

3.2.22.1 Product Specifications

3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Intas Pharmaceuticals  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.22.3 Recent Developments

3.2.22.4 Future Strategic Planning

3.2.23 Karyopharm Therapeutics  Overview

Table Karyopharm Therapeutics  Overview List

3.2.23.1 Product Specifications

3.2.23.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Karyopharm Therapeutics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.23.3 Recent Developments

3.2.23.4 Future Strategic Planning

3.2.24 Kyowa Hakko Kirin  Overview

Table Kyowa Hakko Kirin  Overview List

3.2.24.1 Product Specifications

3.2.24.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Kyowa Hakko Kirin  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.24.3 Recent Developments

3.2.24.4 Future Strategic Planning

3.2.25 Ligand Pharmaceuticals Overview

Table Ligand Pharmaceuticals Overview List

3.2.25.1 Product Specifications

3.2.25.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Drugs for Non-small Cell Lung Cancer Business Operation of Ligand Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.25.3 Recent Developments

3.2.25.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

Figure Global Market Size and Growth Rate, 2016-2020, in Volume

Figure Global Market Size and Growth Rate, 2016-2020, in Million USD

Figure Global Competition Sketch Overview

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

Table Global Production Volume List by Manufacturers, 2016-2020, in Volume

Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume

Figure Global Production Volume Share by Manufacturers in 2020, in Volume

Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD

Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD

Figure Global Production Amount Share by Manufacturers in 2020, in Million USD

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume

5.2 Segment Subdivision by Product Type

5.2.1 Market in Radiofrequency Ablation (RFA) 

5.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Radiofrequency Ablation (RFA) , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Radiofrequency Ablation (RFA) , 2016-2020, in Volume

5.2.1.2 Situation & Development

5.2.2 Market in Radiation Therapy 

5.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Radiation Therapy , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Radiation Therapy , 2016-2020, in Volume

5.2.2.2 Situation & Development

5.2.3 Market in Chemotherapy 

5.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Chemotherapy , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Chemotherapy , 2016-2020, in Volume

5.2.3.2 Situation & Development

5.2.4 Market in Targeted Therapies 

5.2.4.1 Market Size

Figure Global Market Amount and Growth Rate in Targeted Therapies , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Targeted Therapies , 2016-2020, in Volume

5.2.4.2 Situation & Development

5.2.5 Market in Immunotherapy

5.2.5.1 Market Size

Figure Global Market Amount and Growth Rate in Immunotherapy, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Immunotherapy, 2016-2020, in Volume

5.2.5.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume

6.2 Segment Subdivision

6.2.1 Market in Hospital 

6.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Hospital , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Hospital , 2016-2020, in Volume

6.2.1.2 Situation & Development

6.2.2 Market in Clinic 

6.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Clinic , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Clinic , 2016-2020, in Volume

6.2.2.2 Situation & Development

6.2.3 Market in Others

6.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Others, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2016-2020, in Volume

6.2.3.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

Table Global Market Forecast by Region Segment 2021-2026, in Million USD

Table Global Market Forecast by Region Segment 2021-2026, in Volume

7.2 Consumption Forecast

7.2.1 Product Type Forecast

Table Global Market Amount by Product Type Segment 2021-2026, in Million USD

Table Global Market Volume by Product Type Segment 2021-2026, in Volume

7.2.2 End-Use Forecast

Table Global Market Amount by End-Use Segment 2021-2026, in Million USD

Table Global Market Volume by End-Use Segment 2021-2026, in Volume

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

Figure Cost Component Ratio

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

9.3 Impact of Coronavirus on the Drugs for Non-small Cell Lung Cancer Industry

9.3.1 Impact on Industry Upstream

9.3.2 Impact on Industry Downstream

9.3.3 Impact on Industry Channels

9.3.4 Impact on Industry Competition

9.3.5 Impact on Industry Employment

10 Research Conclusion

Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026

Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026

Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026

Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume

Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD

Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume

Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

Table Bristol-Myers Squibb  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Bristol-Myers Squibb  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GlaxoSmithKline  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of GlaxoSmithKline  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Menarini  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Menarini  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sanofi  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Sanofi  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Ziopharm Oncology  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Ziopharm Oncology  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Alchemia  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Alchemia  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Amgen  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Amgen  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Apotex  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Apotex  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table BioMarin Pharmaceutical  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of BioMarin Pharmaceutical  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table CellAct Pharma  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of CellAct Pharma  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Cerulean Pharma  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cerulean Pharma  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Cipla  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cipla  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Cornerstone Pharmaceuticals  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cornerstone Pharmaceuticals  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Curis  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Curis  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table CytRx  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of CytRx  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Eli Lilly  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Eli Lilly  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Exelixis  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Exelixis  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Fresenius Kabi  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Fresenius Kabi  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Genentech  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Genentech  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Hikma Pharmaceuticals  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Hikma Pharmaceuticals  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Hospira  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Hospira  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Intas Pharmaceuticals  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Intas Pharmaceuticals  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Karyopharm Therapeutics  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Karyopharm Therapeutics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Kyowa Hakko Kirin  Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Kyowa Hakko Kirin  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Ligand Pharmaceuticals Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Ligand Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2016-2020, in Volume

Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume

Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD

Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume

Table Global Market Forecast by Region Segment 2021-2026, in Million USD

Table Global Market Forecast by Region Segment 2021-2026, in Volume

Table Global Market Amount by Product Type Segment 2021-2026, in Million USD

Table Global Market Volume by Product Type Segment 2021-2026, in Volume

Table Global Market Amount by End-Use Segment 2021-2026, in Million USD

Table Global Market Volume by End-Use Segment 2021-2026, in Volume